Analysis of naloxone usage, safety, and efficacy in the emergency department and prehospital environment during the covid-19 pandemic

Ended Definitive Contract Awarded Last action

Contract number
75F40122C00185
Awardee
Awarding agency
Obligated
$119,160

Award facts

Contract value 22% obligated
  • $119,160.00 Current, with exercised options
  • $549,175.31 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
1 offer Basic Research
Pricing
Cost No Fee
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $119,160

About this award

The Food and Drug Administration awarded a $549,175.31 definitive contract to American College Of Emergency Physicians for analysis of naloxone usage, safety, and efficacy in the emergency department and prehospital environment during the COVID-19 pandemic on September 21, 2022, under cost-no-fee pricing with no set-aside.

Place of performance is Silver Spring, MD. The ultimate completion date is September 29, 2024.

Quick answers

Who was awarded contract 75F40122C00185?

75F40122C00185 was awarded to American College Of Emergency Physicians by Food and Drug Administration (Department of Health and Human Services) on September 21, 2022.

How much is contract 75F40122C00185 worth?

The government has obligated $119,160 on 75F40122C00185. Its potential value, with all options, is $549,175.

Was contract 75F40122C00185 competed?

The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award